OptiBiotix Health director leaves for role at probiotic unit
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
U.K.-based OptiBiotix Health PLC announced the departure of director Per Rehne.
Rehne will still remain as a director of OptiBiotix's newly formed probiotic subsidiary ProBiotix Health Ltd.
OptiBiotix Health develops microbial strains, compounds and formulations that modulate the human microbiome and impact lipid and cholesterol management, energy harvest and appetite-suppression activities.
